These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 32224882)

  • 21. Anti-Glycolytic Drugs in the Treatment of Hepatocellular Carcinoma: Systemic and Locoregional Options.
    Pourbaghi M; Haghani L; Zhao K; Karimi A; Marinelli B; Erinjeri JP; Geschwind JH; Yarmohammadi H
    Curr Oncol; 2023 Jul; 30(7):6609-6622. PubMed ID: 37504345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful Transcatheter Arterial Radioembolization of Hepatocellular Carcinoma Via Left Internal Mammary Artery: A Case Report.
    Alhussaini A; Qazi SA; AlZahrani YA
    Cureus; 2022 Mar; 14(3):e22954. PubMed ID: 35411262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transarterial chemoembolization, transarterial chemotherapy, and intra-arterial chemotherapy for hepatocellular carcinoma treatment.
    Tsochatzis EA; Germani G; Burroughs AK
    Semin Oncol; 2010 Apr; 37(2):89-93. PubMed ID: 20494700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survival analysis of 230 patients with unresectable hepatocellular carcinoma treated with bland transarterial embolization.
    Lanza E; Muglia R; Bolengo I; Poretti D; D'Antuono F; Ceriani R; Torzilli G; Pedicini V
    PLoS One; 2020; 15(1):e0227711. PubMed ID: 31935255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system.
    Han K; Kim JH
    World J Gastroenterol; 2015 Sep; 21(36):10327-35. PubMed ID: 26420959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intra arterial treatment of hepatocellular carcinoma: Comparison of MELD score variations between radio-embolization and chemo-embolization.
    Delicque J; Hermida M; Piron L; Allimant C; Belgour A; Pageaux GP; Ben Bouallegue F; Assenat E; Mariano-Goulart D; Guiu B; Cassinotto C
    Diagn Interv Imaging; 2019 Nov; 100(11):689-697. PubMed ID: 31281074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Review on transarterial chemoembolization in hepatocellular carcinoma: palliative, combined, neoadjuvant, bridging, and symptomatic indications.
    Vogl TJ; Naguib NN; Nour-Eldin NE; Rao P; Emami AH; Zangos S; Nabil M; Abdelkader A
    Eur J Radiol; 2009 Dec; 72(3):505-16. PubMed ID: 18835117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The cost-effectiveness of TheraSphere in patients with hepatocellular carcinoma who are eligible for transarterial embolization.
    Manas D; Bell JK; Mealing S; Davies H; Baker H; Holmes H; Hubner RA
    Eur J Surg Oncol; 2021 Feb; 47(2):401-408. PubMed ID: 32958370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.
    Marelli L; Shusang V; Buscombe JR; Cholongitas E; Stigliano R; Davies N; Tibballs J; Patch D; Meyer T; Burroughs AK
    J Nucl Med; 2009 Jun; 50(6):871-7. PubMed ID: 19443599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transarterial chemoembolization for hepatocellular carcinoma: A review of techniques.
    Imai N; Ishigami M; Ishizu Y; Kuzuya T; Honda T; Hayashi K; Hirooka Y; Goto H
    World J Hepatol; 2014 Dec; 6(12):844-50. PubMed ID: 25544871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the survival and tolerability of radioembolization in elderly vs. younger patients with unresectable hepatocellular carcinoma.
    Golfieri R; Bilbao JI; Carpanese L; Cianni R; Gasparini D; Ezziddin S; Paprottka PM; Fiore F; Cappelli A; Rodriguez M; Ettorre GM; Saltarelli A; Geatti O; Ahmadzadehfar H; Haug AR; Izzo F; Giampalma E; Sangro B; Pizzi G; Notarianni E; Vit A; Wilhelm K; Jakobs TF; Lastoria S;
    J Hepatol; 2013 Oct; 59(4):753-61. PubMed ID: 23707371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transarterial Therapies for Hepatocellular Carcinoma: a Comprehensive Review with Current Updates and Future Directions.
    Kumar Y; Sharma P; Bhatt N; Hooda K
    Asian Pac J Cancer Prev; 2016; 17(2):473-8. PubMed ID: 26925630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of hepatocellular in the United States.
    Mokdad AA; Hester CA; Singal AG; Yopp AC
    Chin Clin Oncol; 2017 Apr; 6(2):21. PubMed ID: 28482674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rethinking the Role of Radiation Therapy in the Treatment of Unresectable Hepatocellular Carcinoma: A Data Driven Treatment Algorithm for Optimizing Outcomes.
    Sayan M; Yegya-Raman N; Greco SH; Gui B; Zhang A; Chundury A; Grandhi MS; Hochster HS; Kennedy TJ; Langan RC; Malhotra U; Rustgi VK; Shah MM; Spencer KR; Carpizo DR; Nosher JL; Jabbour SK
    Front Oncol; 2019; 9():345. PubMed ID: 31275846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Embolotherapy of unresectable hepatocellular carcinoma: Eastern perspective.
    Lu J; Zhong BY; Zhu HD; Guo JH; Teng GJ
    Chin Clin Oncol; 2019 Dec; 8(6):60. PubMed ID: 31865712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of Trans-Arterial Chemoembolization and Bland Embolization for the Treatment of Hepatocellular Carcinoma: A Propensity Score Analysis.
    Roth GS; Benhamou M; Teyssier Y; Seigneurin A; Abousalihac M; Sengel C; Seror O; Ghelfi J; Ganne-Carrié N; Blaise L; Sutter O; Decaens T; Nault JC
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33672012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trans-arterial chemoembolization with degradable starch microspheres (DSM-TACE) versus selective internal radiation therapy (SIRT) in multifocal hepatocellular carcinoma.
    Auer TA; Jonczyk M; Collettini F; Marth A; Wieners G; Hamm B; Gebauer B
    Acta Radiol; 2021 Mar; 62(3):313-321. PubMed ID: 32498543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Addressing the worldwide hepatocellular carcinoma: epidemiology, prevention and management.
    Samant H; Amiri HS; Zibari GB
    J Gastrointest Oncol; 2021 Jul; 12(Suppl 2):S361-S373. PubMed ID: 34422400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of transcatheter embolization/chemoembolization (TAE/TACE) for the treatment of single hepatocellular carcinoma.
    Miraglia R; Pietrosi G; Maruzzelli L; Petridis I; Caruso S; Marrone G; Mamone G; Vizzini G; Luca A; Gridelli B
    World J Gastroenterol; 2007 Jun; 13(21):2952-5. PubMed ID: 17589945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management and Treatment of Hepatocellular Carcinoma with Immunotherapy: A Review of Current and Future Options.
    Ghavimi S; Apfel T; Azimi H; Persaud A; Pyrsopoulos NT
    J Clin Transl Hepatol; 2020 Jun; 8(2):168-176. PubMed ID: 32832397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.